CD19 and myelodysplastic syndrome: In the analysis of the lymphoid markers on the CD34+ stem cells, we found that the percentage of positive markers (CD7 for T cells and CD19 for B cells) on these cells was similar for the MDS/LA+ and MDS/LA- groups (Table 2).